Evidence map›Paper›PMID 30717378›Full record

ArticleInternational journal of molecular sciences2019

Combining TIR and FRET in Molecular Test Systems.

Herbert Schneckenburger, Petra Weber, Michael Wagner, Sandra Enderle, Bernd Kalthof, Linn Schneider, Claudia Herzog, Julian Weghuber, Peter Lanzerstorfer

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Lasers in Live Cell Microscopy.International journal of molecular sciences · 2022
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Herbert SchneckenburgerInstitute of Applied Research, Aalen University, 73430 Aalen, Germany. Herbert.Schneckenburger@hs-aalen.de.
Petra WeberInstitute of Applied Research, Aalen University, 73430 Aalen, Germany. Petra.Weber@hs-aalen.de.
Michael WagnerInstitute of Applied Research, Aalen University, 73430 Aalen, Germany. Michael.Wagner@hs-aalen.de.
Sandra EnderleInstitute of Applied Research, Aalen University, 73430 Aalen, Germany. sandra-enderle@gmx.de.
Bernd KalthofPharmaceutical Division, Bayer AG, 42096 Wuppertal, Germany. bernd.kalthof@bayer.com.
Linn SchneiderPharmaceutical Division, Bayer AG, 42096 Wuppertal, Germany. linn.schneider@bayer.com.
Claudia HerzogPharmaceutical Division, Bayer AG, 42096 Wuppertal, Germany. claudia.herzog@bayer.com.
Julian WeghuberUniversity of Applied Sciences Upper Austria, 4600 Wels, Austria. Julian.Weghuber@fh-wels.at.ORCID 0000-0001-6312-4666
Peter LanzerstorferUniversity of Applied Sciences Upper Austria, 4600 Wels, Austria. Peter.Lanzerstorfer@fh-wels.at.
Hochschule Aalen · DEBayer (Germany) · DEUniversity of Applied Sciences Upper Austria · AT

Funding

Österreichische Forschungsförderungsgesellschaft 850681
6 · The paper itself

Abstract

Pharmaceutical agents or drugs often have a pronounced impact on protein-protein interactions in cells, and in particular, cell membranes. Changes of molecular conformations as well as of intermolecular interactions may affect dipole-dipole interaction between chromophoric groups, which can be proven by measuring the Förster resonance energy transfer (FRET). If these chromophores are located within or in close proximity to the plasma membrane, they are excited preferentially by an evanescent electromagnetic wave upon total internal reflection (TIR) of an incident laser beam. For the TIR-FRET screening of larger cell collectives, we performed three separate steps: (1) setting up of a membrane associated test system for probing the interaction between the epidermal growth factor receptor (EGFR) and the growth factor receptor-bound protein 2; (2) use of the Epac-SH188 sensor for quantitative evaluation under the microscope; and (3) application of a TIR fluorescence reader to probe the interaction of GFP with Nile Red. In the first two steps, we measured FRET from cyan (CFP) to yellow fluorescent protein (YFP) by spectral analysis and fluorescence lifetime imaging (FLIM) upon illumination of whole cells (epi-illumination) as well as selective illumination of their plasma membranes by TIR. In particular, TIR excitation permitted FRET measurements with high sensitivity and low background. The Epac sensor showed a more rapid response to pharmaceutical agents, e.g., Forskolin or the A2B adenosine receptor agonist NECA, in close proximity to the plasma membrane compared to the cytosol. Finally, FRET from a membrane associated GFP to Nile Red was used to test a multi-well TIR fluorescence reader with simultaneous detection of a larger number of samples.

Indexed as

Fluorescence Resonance Energy TransferMolecular Diagnostic TechniquesBiosensing TechniquesErbB ReceptorsGene ExpressionGenes, ReporterHumansLuminescent ProteinsMicroscopy, FluorescenceEGFR protein, humanErbB ReceptorsLuminescent Proteinsdrug screeningfluorescence lifetime imaging (FLIM)fluorescence readerfluorescence spectroscopyFörster resonance energy transfer (FRET)living cellsmicroscopytotal internal reflection (TIR)

Identifiers

PMID30717378
PMCPMC6387052
OpenAlexW2911693681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.